Table I.
Baseline characteristics of the subjects included in the analysis
| Characteristic | PIONEER I placebo (n = 141) | PIONEER II placebo (n = 121) |
|---|---|---|
| Gender | ||
| Female | 99 (70.2%) | 90 (74.4%) |
| Male | 42 (29.8%) | 31 (25.6%) |
| Race | ||
| White | 110 (78.0%) | 98 (81.0%) |
| Black | 24 (17.0%) | 15 (12.4%) |
| Other | 7 (5.0%) | 8 (6.6%) |
| Median Age∗ | 36.0 (30.0-47.0) | 33.0 (26.0-42.0) |
| Median BMI∗ | 33.8 (28.4-39.3) | 31.7 (26.5-36.5) |
| BMI category | ||
| Underweight/normal | 12 (8.5%) | 22 (18.3%) |
| Overweight | 35 (24.8%) | 23 (19.2%) |
| Obese | 94 (66.7%) | 75 (62.5%) |
| Hurley stage | ||
| 2 | 75 (53.2%) | 74 (61.2%) |
| 3 | 66 (46.8%) | 47 (38.8%) |
| Nicotine use | 85 (60.3%) | 89 (74.2) |
| Family history | 28 (19.9%) | 31 (25.6%) |
| Presence of draining tunnels | 104 (73.8%) | 73 (60.3%) |
| Median inflammatory nodules∗ | 7 (4-15) | 6 (4-10) |
| Median abscesses∗ | 2 (0-3) | 1 (0-3) |
| Median AN count∗ | 11 (6-17) | 8 (5-13) |
| Median draining tunnels∗ | 2 (0-5) | 1 (0-3) |
| Median baseline IHS4∗ | 25 (13-40) | 1 (9-30) |
Data are presented as n values with percentages for categorical variables.
AN, Abscess and nodule.
∗
Data are presented as medians with interquartile ranges in parentheses.